172 related articles for article (PubMed ID: 2124160)
1. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis.
Dasgupta B; Panayi GS
Br J Rheumatol; 1990 Dec; 29(6):456-8. PubMed ID: 2124160
[TBL] [Abstract][Full Text] [Related]
2. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
3. Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.
Dasgupta B; Duke O; Timms AM; Pitzalis C; Panayi GS
Ann Rheum Dis; 1989 Apr; 48(4):307-11. PubMed ID: 2653244
[TBL] [Abstract][Full Text] [Related]
4. Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
Pountain GD; Keogan MT; Brown DL; Hazleman BL
Ann Rheum Dis; 1993 Oct; 52(10):730-3. PubMed ID: 8257209
[TBL] [Abstract][Full Text] [Related]
5. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.
Roche NE; Fulbright JW; Wagner AD; Hunder GG; Goronzy JJ; Weyand CM
Arthritis Rheum; 1993 Sep; 36(9):1286-94. PubMed ID: 8216422
[TBL] [Abstract][Full Text] [Related]
6. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
Macchioni P; Boiardi L; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I
Br J Rheumatol; 1993 Aug; 32(8):666-70. PubMed ID: 8348267
[TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.
Caplanne D; Le Parc JM; Alexandre JA
Ann Rheum Dis; 1996 Jun; 55(6):403-4. PubMed ID: 8694583
[No Abstract] [Full Text] [Related]
10. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis.
Pountain G; Hazleman B; Cawston TE
Br J Rheumatol; 1998 Jul; 37(7):797-8. PubMed ID: 9714363
[No Abstract] [Full Text] [Related]
12. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
13. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
Pountain G; Keogan M; Hazleman B; Brown D
Br J Rheumatol; 1994 Feb; 33(2):194-5. PubMed ID: 8162492
[No Abstract] [Full Text] [Related]
15. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.
Wagner AD; Goronzy JJ; Weyand CM
J Clin Invest; 1994 Sep; 94(3):1134-40. PubMed ID: 8083354
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
17. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.
Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
Ann Intern Med; 1994 Oct; 121(7):484-91. PubMed ID: 8067646
[TBL] [Abstract][Full Text] [Related]
18. CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset.
Elling H; Elling P; Olsson A
Clin Exp Rheumatol; 1989; 7(6):627-30. PubMed ID: 2533002
[TBL] [Abstract][Full Text] [Related]
19. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Chalan P; Rutgers A; Horst G; Huitema MG; Roffel MP; Roozendaal C; Kluin PM; Bos NA; Boots AM; Brouwer E
Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
[TBL] [Abstract][Full Text] [Related]
20. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
Kyle V; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
